Updates in outcomes of stereotactic radiation therapy in acromegaly
Conclusion Although the use of radiotherapy in patients with acromegaly has decreased with advances in medical treatments, it remains an effective treatment option after unsuccessful surgery and/or resistance or unavailability of medical therapy. Long-term studies evaluating secondary morbidity and mortality rate after the new stereotactic techniques are needed, in order to evaluate their potential brain-sparing effect.
Source: Pituitary - Category: Endocrinology Source Type: research
More News: Acromegaly | Brain | Brain Cancers | Brain Tumor | Endocrinology | Hormones | Neurology | Radiation Therapy | Stroke | Study | Toxicology